This is not a big deal: Jefferies managing director on Eli Lilly pausing Covid-19 trials

50

Eli Lilly’s phase three trial of its monoclonal antibody treatment for coronavirus has been paused due to potential safety concerns. This comes shortly after Johnson and Johnson and AstraZeneca also paused its Covid-19 clinical trials. Michael…